Global Health Tech Unicorns

The Complete List of Global Health Tech Unicorns

Global Health Tech Unicorns

A unicorn startup or unicorn company is a private company with a valuation over $1 billion USD. Unicorns are ‘startups’, i.e they do not include post-exit, acquired or listed companies, nor do they include ‘mature’ incumbents.

As of 2 Aug 2022, there are 96 HealthTech Unicorns around the world who are now collectively valued at $231B+

Recent Health Tech Unicorn Developments

Tebra joined the list in Jul 2022.

CareBridge and Visby Medical joined the list in Jun 2022.

Reify Health, Oura, Clarify Health, IntelyCare, NexHealth, BostonGene and Biofourmis joined the list in Apr 2022.

BenevolentAI left the list in Apr 2022 via SPAC.

Somatus and Omada Health joined the list in Feb 2022.

Saliogen Therapeutics, Athelas, Athletic Greens and Transcarent joined the list in Jan 2022.

Pristyn Care and Cadence Solutions joined the list in Dec 2021.

EQRx left the list in Dec 2021 via IPO.

Pear Therapeutics was acquired by Thimble Point (SPAC) in Dec 2021.

Abogen, SWORD Health, Curefit and Papa joined the list in Nov 2021.

Elemy, Dental Monitoring, and Truepill joined the list in Oct 2021.

VillageMD was acquired by Walgreens Boots Alliance in Oct 2021.

Babylon Health and Oxford Nanopore Technologies left the list in Oct 2021 via IPO.

Spring Health, Mammoth Biosciences and TrialSpark joined the list in Sep 2021.

Ginkgo BioWorks left the list in Sep 2021 via IPO.

Maven Clinic joined the list in Aug 2021.

Grail was acquired by Illumina in Aug 2021.

Rani Therapeutics, Lyell Immunopharma and Brii Biosciences left the list in Jul 2021 via IPO.

PharmEasy, Prime Medicine, Cerebral, SonderMind, Carbon Health, Yaoshibang and dMed Biopharmaceutical joined the list in Jun – Jul 2021.

ATAI Life Sciences and Bright Health left the list in Jun 2021 via IPO.

Roivant Sciences left the list in May 2021 via IPO.

Capsule, KRY, Caris Life Sciences, Collective Health, Noom, Valgen Medtech, Fiture joined the list in Apr – May 2021.

Outcome Health was acquired by PatientPoint in Mar 2021.

Aledade, EQRx, Innovaccer, ATAI Life Sciences, Brii BioSciences, Evidation Health, Ginger, Komodo Health, Radiology Partners, Rightway, Unite Us, DispatchHealth, Pear Therapeutics, Insitro and Shulan Health joined the list in Jan – Mar 2021.

Recursion Pharmaceuticals left the list in Apr 2021 via IPO.

Oscar Health left the list in Mar 2021 via IPO.

Sema4 was acquired by Casdin Capital and Corvex Management (SPAC) in Feb 2021.

23andMe was acquired by Virgin Galactic Acquisition Corporation (SPAC) in Feb 2021.

Clover Health left the list in Jan 2021 via IPO.

The Complete List of Global Health Tech Unicorns

Company

Country

Industry

Last Round

Type

Valuation

United States

Finance

Oct 2021

$1.15B Series D

$12.7B

United States

Research

Apr 2021

$120M VC Round

$12.4B

United States

Research

Dec 2020

$200 M Series G-2

$8B

United States

Research

May 2021

$830M PE Round

$7.83B

China

Treatment

Feb 2021

$411M Series F

$7B

France

Systems

Mar 2022

$549M Series F

$6.4B

United States

Hardware

Oct 2021

$600M Series E

$6.2B

United States

Prevention

Jan 2022

$235M Series F

$5.85B

United States

Finance

Sep 2021

$400M Series D

$5.7B

China

Hardware

Sep 2017

$500M Series A

$5.1B

United States

Treatment

Mar 2021

$500M Series D

$5B

United States

Research

Apr 2022

$220M Series D

$4.8B

United States

Prevention

Dec 2021

$300M Series C

$4.8B

United States

Diagnosis

Nov 2021

$100M Series E

$4.6B

United States

Systems

Jun 2021

$400M Series H

$4B

United States

Diagnosis

Mar 2021

$12.6M Venture Round

$4B

China

Treatment

Dec 2021

$514 Milion Series E

$3.9B

United States

Research

Aug 2019

Undisclosed

$3.8B

China

Research

Nov 2021

$300M Series C

$3.7B

United States

Prevention

May 2021

$540M Series F

$3.7B

Germany

Hardware

Dec 2019

$106.9M Debt

$3.5B

India

Supply Chain

Nov 2021

Private Equity

$3.4B

United States

Systems

Mar 2021

$220M Series E

$3.3B

United States

Systems

Dec 2021

$150M Series E

$3.1B

United States

Treatment

Jul 2021

$350M Series D

$3B

United Kingdom

Hardware

Jun 2021

$600M Series D

$3B

Finland

Hardware

Apr 2022

VC Round

$2.55B

United States

Care

Feb 2022

$325M Series E

$2.5B

United States

Research

Mar 2021

$400M Series C

$2.4B

United States

Care

Nov 2021

$163M Series D

$2B

United States

Prevention

Sep 2021

$190M Series C

$2B

Sweden

Treatment

Apr 2021

$319M Series D

$2B

United States

Care

Apr 2021

$133M Series D

$1.9B

China

Prevention

Jan 2021

$360M Series F

$1.9B

United States

Treatment

Jan 2021

$100M Series D

$1.9B

United States

Prevention

Dec 2020

$75M Series C

$1.9B

United States

Systems

Aug 2015

$130M Series D

$1.8B

United States

Research

Jan 2022

$115M Series B

$1.7B

United States

Treatment

Mar 2021

$200M Series D

$1.7B

United States

Systems

Mar 2021

$150M Series C

$1.7B

United States

Supply Chain

Oct 2021

$142M Series D

$1.6B

United States

Research

Dec 2020

$700M VC Round

$1.6B

United States

Systems

Jan 2022

$132M VC Round

$1.5B

United States

Prevention

Nov 2021

$145M Series F

$1.5B

United States

Finance

May 2021

$280M Series F

$1.5B

United States

Treatment

Jan 2021

$132M Series E

$1.5B

United States

Prevention

Nov 2020

$110M Series F

$1.5B

United States

Diagnosis

Jun 2019

$65M Series E

$1.5B

China

Research

May 2021

$188M Series B

$1.43B

United States

Systems

Apr 2022

$150M Series D

$1.4B

India

Systems

Dec 2021

$96M Series E

$1.4B

United States

Care

Nov 2021

$150M Series D

$1.4B

China

Supply Chain

Jul 2021

$270M Series E

$1.35B

United States

Prevention

Jan 2022

$115M VC Round

$1.32B

United States

Research

Apr 2022

$50M Series D

$1.31B

China

Treatment

Mar 2021

Series D

$1.24B

United States

Care

Oct 2021

$219M Series B

$1.2B

United States

Research

July 2021

$200M Series B

$1.2B

Israel

Research

Apr 2021

$136M Venture Series Unknown

$1.2B

United States

Prevention

Feb 2021

$74M Series D

$1.2B

United States

Workforce

Apr 2022

$115M Series C

$1.1B

United States

Prevention

Mar 2021

$100M Series E

$1.1B

United States

Finance

Mar 2021

$100M Series C

$1.1B

United States

Treatment

Jun 2022

$140M Venture Round

$1B+

United States

Diagnosis

Jun 2022

$35M Series E

$1B+

United States

Systems

Jul 2022

$72M Series B

$1B

Singapore

Research

Apr 2022

$320M Series D

$1B

United States

Diagnosis

Apr 2022

$150M Series B

$1B

United States

Systems

Apr 2022

$125M Series C

$1B

United States

Care

Feb 2022

$192M Series E

$1B

Switzerland

Treatment

Feb 2022

$105M Venture Series Unknown

$1B

Switzerland

Systems

Feb 2022

$53.4M Venture Series Unknown

$1B

United States

Systems

Jan 2022

$200M Series C

$1B

United States

Supply Chain

Jan 2022

$200M Series E

$1B

United States

Prevention

Dec 2021

$100M Series B

$1B

France

Prevention

Oct 2021

$150M PE Round

$1B

United States

Research

Sep 2021

$156M Series C

$1B

United States

Research

Sep 2021

$150M Series D

$1B

China

Treatment

Aug 2021

$232M Series F

$1B

United States

Treatment

Aug 2021

$110M Series D

$1B

China

Research

Jul 2021

$50M Series C

$1B

United States

Prevention

Jul 2021

$150M Series C

$1B

Ireland

Diagnosis

Jun 2021

$150M Series D

$1B

United States

Care

Jun 2021

$140M Series C

$1B

United States

Supply Chain

Apr 2021

$300M Series D

$1B

China

Prevention

Apr 2021

$300M Series B

$1B

United States

Prevention

Mar 2021

$153M Series E

$1B

United States

Prevention

Sep 2020

$450M Series C

$1B

United States

Research

Jun 2020

$192M Series D

$1B

United States

Prevention

Jun 2019

$300M Series D

$1B

South Korea

Research

May 2019

-

$1B

China

Research

Jul 2018

$151M Series D

$1B

China

Research

Jun 2018

$141.77M Series A

$1B

China

Treatment

Apr 2018

$100M Series D

$1B

United States

Systems

Feb 2018

$146M Series D

$1B

Israel

Hardware

Feb 2018

$30.4M VC Round

$1B

Ready to get started?

Get a personalized walkthrough of HolonIQ's Global Intelligence Platform.

arrow right

Sign up for our free weekly newsletters

Join 80,000+ free weekly newsletter subscribers.